Now with 111 pharmacies participating in NAC's Medical
Cannabis Management System, National Access Cannabis Medical
continues to expand its base of partner pharmacies across
Canada
OTTAWA, Oct. 22, 2018 /CNW/ - National Access
Cannabis Corp. ("NAC" or the "Company") (TSXV: META), a best
practices leader in delivering secure, safe, and responsible access
to legal cannabis in Canada today
announced the signing of Pharmacy Cannabis Program Agreements with
70 pharmacies in Canada that will
be participating in the National Access Cannabis Medical Inc.
("NACM") Medical Cannabis Management System™ ("MCMS") in
addition to those announced in April
2018, bringing the total number of pharmacies working with
NACM to 111.
"We see this as tremendous growth for NAC," said Mark Goliger, CEO of NAC. "This unique pharmacy
partnership is a key pillar of our diversified cannabis business.
The medical cannabis market in Canada is forecast to surpass $2B by 2020 (Deloitte, 2018), and as experienced
medical clinic operators, we're excited to grow our medical
division and broaden our ability to provide safe and responsible
access to legal medical cannabis."
"The pharmacy application of the Medical Cannabis Management
System provides a structured process and opportunity for
independent pharmacies to enhance their involvement in medical
cannabis therapy, by utilizing resources provided by NACM,"
explained Pram Sandhu, VP Medical Operations & Business
Optimization. "It was designed with input from pharmacists, for
pharmacists. We're thrilled by the opportunity to work with our new
pharmacy partners toward the collective goal of improving medical
cannabis related patient care."
MCMS provides pharmacies with a turnkey medical cannabis program
for their patients and, when legally permissible, assistance with
management of product sourcing and distribution. The MCMS program
roll-out was recently initiated with the on-boarding of a pilot
pharmacy, a 2-day educational event for healthcare providers, and
plans for systematic training to be launched across partner
pharmacies in Ontario,
British Columbia, Alberta and Saskatchewan. NACM continues to negotiate with
pharmacies across Canada and is on
target to enter into agreements with more than 150 pharmacies by
late 2018-early 2019.
NACM facilitates the safe and responsible use of medical
cannabis by connecting patients with knowledgeable healthcare
practitioners, coordinating clinic visits, managing medical
cannabis education, providing assistance with product selection,
coordinating patient registration with Health Canada approved
Licensed Producers (LPs) and continued patient follow-up. After an
initial on-boarding period, NACM anticipates assisting more than
200 potential medical cannabis patients per pharmacy per year,
through its current roster of 111 partner pharmacies.
About National Access Cannabis Corp.
NAC is a best practices leader in delivering secure,
safe, and responsible access to legal cannabis in Canada. Through its Canada-wide network
of medical cannabis clinics, partner pharmacies, NAC Bio's clinical
research division, NewLeaf Cannabis™ and Meta Cannabis Supply Co.™
recreational cannabis retail stores, NAC enables patients and the
public to gain knowledge and access to Canada's network
of authorized Licensed Producers of cannabis. NAC is listed on the
TSX Venture Exchange under the symbol (TSXV: META).
For more information, visit:
www.nacmedical.com
www.nationalaccesscannabis.com
www.nacbio.com
www.metacannabis.com
www.newleafcannabis.ca
Cautionary Statements
This news release contains forward looking statements and
forward-looking information within the meaning of applicable
securities laws. The use of any of the words "expect",
"anticipate", "continue", "estimate", "objective", "ongoing",
"may", "will", "project", "should", "believe", "plans", "intends"
and similar expressions are intended to identify forward
looking statements or information. Forward-looking statements and
information in this news release includes, but is not limited to,
entering into additional agreements with pharmacies, and changing
regulations to permit NAC to assist pharmacies with product
sourcing and distribution. Although the Company believes
that the expectations and assumptions on which the
forward-looking statements and information are based are
reasonable, undue reliance should not be placed on the
forward-looking statements and information because the Company
cannot give any assurance that they will prove to be
correct. Since forward looking statements and information
address future events and conditions, by their very nature they
involve inherent risks and uncertainties. Actual results and
developments may differ materially from those that are currently
contemplated by these statements depending on, among other things,
risks relating to the ability to obtain or maintain licenses to
retail cannabis products; future legislative and regulatory
developments involving cannabis; inability to access sufficient
capital from internal and external sources, and/or inability to
access sufficient capital on favourable terms; the labour market
generally and the ability to access, hire and retain employees; and
the medical and potential cannabis industry in Canada generally. The Company cautions that
the foregoing list of risks and uncertainties is not
exhaustive.
The forward-looking statements and information contained in
this news release are made as of the date hereof and the Company
undertakes no obligation to update publicly or revise any
forward-looking statement or information, whether as a result of
new information, future events or otherwise, unless so required by
applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE National Access Cannabis Corp.